Thyroid hormone homeostasis in brain: Possible involvement of adrenergic phenomenon in adult rat

Neuroendocrinology

Volumn 89, Issue 2, 2009, Pages 140-151

  Kundu, Samita ^a   Biswas, Angshuman ^b   Roy, Sumedha ^b   De, Jhuma ^b   Pramanik, Mitali ^b   Ray, Arun K ^b  

^a VIVEKANANDA COLLEGE   (India)

^b BOSE INSTITUTE   (India)

Author keywords

Adrenergic receptor; cAMP; Central homeostasis; Deiodinase II; Thyroid hormone

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CYCLIC AMP; ISOPRENALINE; PROPRANOLOL; THYROID HORMONE; YOHIMBINE;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; BRAIN CORTEX; CALCIUM SIGNALING; HORMONAL REGULATION; LIOTHYRONINE BLOOD LEVEL; LIOTHYRONINE METABOLISM; LIOTHYRONINE SYNTHESIS; MALE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; THYROXINE BLOOD LEVEL;

ADRENERGIC AGENTS; ANIMALS; ANTITHYROID AGENTS; CALCIUM; CEREBRAL CORTEX; DRUG COMBINATIONS; HOMEOSTASIS; IODIDE PEROXIDASE; MALE; PROPYLTHIOURACIL; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; THYROXINE; TRIIODOTHYRONINE;

EID: 61749092315     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000158715     Document Type: Article

References (53)

1. Dratman MB, Crutchfield FL, Gordon JT, Jennings AS: Iodothyronine homeostasis in rat brain during hypo- and hyperthyroidism. Am J Physiol 1983;245:E185-E193.
2. Kundu S, Pramanik M, Roy S, De J, Biswas A, Ray AK: Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat. Life Sci 2006;79:1450-1455.
3. Kundu S, Roy S, De J, Biswas A, Pramanik M, Ray AK: Maintenance of homeostasis for thyroid hormone in the adult rat brain: possible involvement of a nuclear-mediated phenomenon. Neuroendocrinology 2007;86:94-103.
4. Bauer M, Whybrow PC: Thyroid hormone, brain and behaviour; in Pfaff D, Arnold A, Etgen A, Fahrbach S, Rubin R (eds): Hormones, Brain and Behaviour. New York, Academic Press, 2002, vol 2, pp 239-264.
5. Harrison TS: Adrenal, medullary, and thyroid relationship. Physiol Rev 1964;44:161-185.
6. Pupo AS, Minneman KP: Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 2001;6:656-662.
7. Williams RS, Lefkowitz RJ: The effects of thyroid hormone on adrenergic receptors; in Oppenheimer JH, Samuels HH (eds): Molecular Basis of Thyroid Hormone Action. New York, Academic Press, 1983, pp 325-346.
8. Sarkar PK, Ray AK: A simple biochemical approach to differentiate synaptosomes and non-synaptic mitochondria from rat brain. Meth Find Exp Clin Pharmacol 1992;14:493-497.
9. Ködding R, Fuhrmann H, von zur Mühlen A: Investigations on iodothyronine deiodinase activity in the maturing rat brain. Endocrinology 1986;118:1347-1352.
10. 2+ indicators with greatly improved fluorescent properties. J Biol Chem 1985;260:3440-3450.
11. 2+ level and activation of nitric oxide synthase in adult rat cerebral cortex pretreated with 3,5,3′-L-triiodothyronine. Neuropsychopharmacology 2000;22:36-41.
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-254.
13. 2, β, and reuptake sites in cerebral cortex and heart. J Neural Transm 1988;71:195-205.
14. Gross G, Brodde OE, Schumann HJ: Decreased number of β-adrenoceptors in cerebral cortex of hypothyroid rats. Eur J Pharmacol 1980;61:191-194.
15. 1 -adrenoceptors in the cerebral cortex of the rat by thyroid hormones. Naunyn Schmiedebergs Arch Pharmacol 1981;316:45-50.
16. Weiss ER, Kelleher DJ, Woon CH, Soparkar S, Osawa S, Heasley LE, Johnson GL: Receptor activation of G proteins. FASEB J 1988;2:2841-2848.
17. Kirstein SL, Insel PA: Autonomic nervous system pharmacogenomics: a progress report. Pharmacol Rev 2004;56:31-52.
18. 2-adrenoceptor function and β-adrenoceptor binding in the rat brain. J Neural Transm 1984;59:43-55.
19. Dratman MB, Crutchfield FL, Axelrod J, Colburn RW, Thoa N: Localization of triiodothyronine in nerve ending fractions of rat brain. Proc Natl Acad Sci USA 1976;73:941-944.
20. Rozanov CB, Dratman MB: Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic systems. Neuroscience 1996;74:897-915.
21. Gordon JT, Kaminski DM, Rozanov CB, Dratman MB: Evidence that 3,3′,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport. Neuroscience 1999;93:943-954.
22. Cooper DS, Kieffer JD, Halpern R, Saxe V, Mover H, Maloof F, Ridgway EC: Propylthiouracil pharmacology in the rat. II. Effects of PTU on thyroid function. Endocrinology 1983;113:921-928.
23. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23:38-89.
24. Safran M, Farwell AP, Leonard JL: Catalytic activity of type II iodothyronine 5′-deiodinase polypeptide is dependent upon a cyclic AMP activation factor. J Biol Chem 1996;271:16363-16368.
25. Segal J: The in vivo effect of 3,5,3′-triiodothyronine on calcium uptake in several tissues in the rat: evidence for a physiological role of calcium as the first messenger for the prompt action of thyroid hormone at the level of the plasma membrane. Endocrinology 1990;127:17-24.
26. Sarkar PK, Ray AK: Calcium mobilization within hypothyroid adult rat brain synaptosomes. Horm Metab Res 2003;35:562-564.
27. Gerard CM, Lefort A, Christophe D, Libert F, Van Sande J, Dumont JE, Vassart G: Distinct transcriptional effects of cAMP on two thyroid-specific genes: thyroperoxidase and thyroglobulin. Horm Metab Res 1990;23:38-43.
28. Svensson TH, Bunney BS, Aghajanian GK: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 1975;92:291-306.
29. 2-adrenoceptors in the rat cerebral cortex. Eur J Pharmacol 1990;176:281-287.
30. Anden NE, Corrodi H, Fuxe K, Hokfelt B, Hokfelt T, Rydin C, Svensson T: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 1970;9:513-523.
31. 2-adrenoceptors in footshock-induced jumping behavior. Eur J Pharmacol 1983;88:399-401.
32. Atkinson BN, Minneman KP: Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial cultures. J Neurochem 1991;56:587-595.
33. Enan E, Matsumura F: Activation of phosphoinositide/ protein kinase C pathway in rat brain tissue by pyrethroids. Biochem Pharmacol 1993;45:703-710.
34. 2+ elicited by noradrenalin and serotonin in cultured local interneurons of mouse olfactory bulb. Neuroscience 1992;49:193-199.
35. Carvalho SD, Bianco AC, Silva JE: Effects of hypothyroidism on brown adipose tissue adenylyl cyclase activity. Endocrinology 1996;137:5519-5529.
36. 1 -adrenergic mediated excitation of the flexor reflex in rats. J Neurosci 1985;5:1583-1590.
37. Zebrowska-Lupina I, Przegalinski E, Sloniec M, Kleinrok Z: Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic α-adrenoceptors. Naunyn Schmiedebergs Arch Pharmaco 1977;297:227-231.
38. Berry-Kravis E, Freedman SB, Dawson G: Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma x brain hybrid cell line NCB-20. J Neurochem 1984;43:413-420.
39. 1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 1990;348:239-242.
40. Jaffer A, Russell VA, Taljaard JJ: Noradrenergic and dopaminergic modulation of thyrotropin secretion in the rat. Brain Res 1987;404:267-272.
41. Rosenberg PA, Li Y: Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res 1995;692:227-232.
42. 2+ efflux and actin polymerization in peritoneal macrophages stimulated with N-formyl chemotactic peptide. Biochim Biophys Acta 1984;804:230-236.
43. Farwell AP, Leonard JL: Dissociation of actin polymerization and enzyme inactivation in the hormonal regulation of type II iodothyronine 5′-deiodinase activity in astrocytes. Endocrinology 1992;131:721-728.
44. Siegrist-Kaiser CA, Juge-Aubry C, Tranter MP, Ekenbarger DM, Leonard JL: Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel extranuclear action of thyroid hormone. J Biol Chem 1990;265:5296-5302.
45. Courtin F, Chantoux F, Pierre M, Francon J: Induction of type II-5′-deiodinase activity by cyclic adenosine 3′,5′- monophosphate in cultured glial cells. Endocrinology 1988;123:1577-1581.
46. 3 potentiates the adrenergic stimulation of type II 5′-deiodinase activity in cultured rat brown adipocytes. Am J Physiol 1996;271:E15-E23.
47. Martinez-deMena R, Hernandez A, Obregon M-J: Triiodothyronine is required for the stimulation of type II 5′-deiodinase mRNA in rat brown adipocytes. Am J Physiol Endocrinol Metab 2002;282:E1119-E1127.
48. Heyma P, Larkins RG, Higginbotham L, Ng KW: D-Propranolol and D,L-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. Br Med J 1980;281:24-25.
49. Reeves RA, From GL, Paul W, Leenen FH: Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol. Clin Pharmacol Ther 1985;37:157-161.
50. Nemethy Z, Horvath G, Makara GB, Acs Z, Barna I: Catecholaminergic control of intracellular free calcium and β-endorphin secretion of rat pituitary intermediate lobe cells. J Neuroendocrinol 1998;10:85-91.
51. Wagner JP, Seidler FJ, Lappi SE, McCook EC, Slotkin TA: Role of thyroid status in the ontogeny of adrenergic cell signaling in rat brain: β-receptors, adenylate cyclase, ornithine decarboxylase and c-fos protooncogene expression. J Pharmacol Exp Ther 1994;271:472-483.
52. 2-adrenergic receptors. J Biol Chem 1991;266:11915-11922.
53. Raasmaja A: Alpha-1- and beta-adrenergic receptors in brown adipose tissue and the adrenergic regulation of thyroxine 5′-deiodinase. Acta Physiol Scand 1990;590:1-61.